ProfileGDS4095 / 226007_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 80% 81% 81% 81% 81% 82% 81% 81% 81% 80% 81% 82% 81% 81% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep18.833780
GSM709769LY2 SRC1-siRNA tamoxifen treated rep38.9239281
GSM709765LY2 SRC1-siRNA untreated rep39.0540281
GSM709771LY2 SRC1-siRNA untreated rep19.0160781
GSM709772LY2 SRC1-siRNA untreated rep28.9558281
GSM709775LY2 SRC1-siRNA untreated rep49.0959982
GSM709764LY2 control-siRNA tamoxifen treated rep28.9707281
GSM709766LY2 control-siRNA tamoxifen treated rep38.9266481
GSM709768LY2 control-siRNA tamoxifen treated rep18.9244181
GSM709777LY2 control-siRNA tamoxifen treated rep48.8583880
GSM709770LY2 control-siRNA untreated rep38.9729681
GSM709773LY2 control-siRNA untreated rep19.1338482
GSM709774LY2 control-siRNA untreated rep28.9930381
GSM709776LY2 control-siRNA untreated rep49.0271481